Journal of Attention Disorders

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (OnlineFirst[PDF])
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Google Scholar
Right arrow Articles by Faraone, S. V.
Right arrow Articles by Findling, R. L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Faraone, S. V.
Right arrow Articles by Findling, R. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
First published on April 9, 2008
Journal of Attention Disorders 2008, doi:10.1177/1087054708314844
© 2008 SAGE Publications

Article

Effects of Once-Daily Oral and Transdermal Methylphenidate on Sleep Behavior of Children With ADHD

Stephen V. Faraone, PhD*, Stephen J. Glatt, PhD, Oscar G. Bukstein, MD, MPH, Frank A. Lopez, MD, L. Eugene Arnold, MD, and Robert L. Findling, MD

* To whom correspondence should be addressed. E-mail: faraones{at}upstate.edu.


  Abstract
Objective: Methylphenidate is a leading first-line treatment for ADHD. This stimulant has long been suspected to adversely affect sleeping patterns of treated individuals, especially children. There are few studies on the effects of recently developed longer-acting methylphenidate treatments, such as once-daily oral or transdermal formulations, on sleep. Method: The authors examined eight indices of sleep behavior among children treated with either of these two methylphenidate preparations or placebo in a randomized, double-blind, multicenter, parallel-group study. Results: The main predictor of sleep problems was baseline numbers or severity of preexisting sleep problems, whereas the different treatments and placebo varied little in their propensity to elicit such problems. There was no significant relationship between dosage and severity or frequency of sleep problems. Conclusion: The authors found little evidence that methylphenidate treatment (at least in sustained-release forms) was a significant cause of sleep problems in treated children who were carefully titrated to an optimal dose. (J. of Att. Dis. 2008; XX(X) xx-xx)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?